Početna stranicaHLUN-B • CPH
add
H. Lundbeck A/S Class B
Preth. zaklj. cijena
45,28 kr
Dnevni raspon
44,70 kr - 45,46 kr
Godišnji raspon
31,62 kr - 49,38 kr
Tržišna kapitalizacija
43,42 mlr. DKK
Prosječna količina
775,02 tis.
P/E omjer
-
Prinos dividende
-
Vijesti s tržišta
MarketWatch
prije 2 sata
How S&P 500 tends to perform during Thanksgiving week and into New Year’s
Eve
0,20 %
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
| (DKK) | ruj 2024.info | Godišnja promjena |
|---|---|---|
Prihod | 5,72 mlr. | 15,55 % |
Operativni troškovi | 3,67 mlr. | 23,76 % |
Neto dohodak | 777,00 mil. | 14,94 % |
Neto profitabilnost | 13,58 | −0,51 % |
Zarada po dionici | 1,30 | 11,11 % |
EBITDA | 1,43 mlr. | 3,10 % |
Efektivna porezna stopa | −6,15 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
| (DKK) | ruj 2024.info | Godišnja promjena |
|---|---|---|
Gotovinska i kratkoročna ulaganja | 8,32 mlr. | 95,90 % |
Ukupna imovina | 39,52 mlr. | 4,89 % |
Ukupne obveze | 15,68 mlr. | 2,04 % |
Ukupni kapital | 23,84 mlr. | — |
Dionice u optjecaju | 996,15 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 1,89 | — |
Povrat imovine | 6,11 % | — |
Povrat kapitala | 8,67 % | — |
Tok novca
Neto promjena novca
| (DKK) | ruj 2024.info | Godišnja promjena |
|---|---|---|
Neto dohodak | 777,00 mil. | 14,94 % |
Gotovina od poslovanja | 2,30 mlr. | 54,50 % |
Gotovina iz ulaganja | −101,00 mil. | −4,12 % |
Gotovina iz financiranja | −24,00 mil. | 97,05 % |
Neto promjena novca | 2,17 mlr. | 270,77 % |
Slobodan tok novca | 985,25 mil. | −28,86 % |
Više
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine.
Headquartered in Copenhagen, Denmark, Lundbeck has approximately 5,600 employees in more than 50 countries, and their products are registered in more than 100 countries. They have production facilities in Denmark, France and Italy and their research centers are based in Denmark and the US.
Lundbeck is listed on the Copenhagen Stock Exchange.
Lundbeck is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations Wikipedia
Glavni izvršni direktor
Osnovano
14. kol 1915.
Web-lokacija
Zaposlenici
5.500
